by By Joel S. Hirschhorn<\/p>\n
![\"\"](\"http:\/\/stateofthenation.co\/wp-content\/uploads\/2020\/10\/President_Trump_Oct_10_2020_810_500_75_s_c1.jpg\")
President Donald J. Trump address a gathering of peaceful protesters in support of law and order from the Blue Room Balcony on the South Lawn of the White House Saturday, October 10, 2020, in his first official event since recovering from the coronavirus. Shealah Craighead \/ White House Flickr<\/p><\/div>\n
October 19, 2020 (LifeSiteNews<\/a>) \u2013 Narcissist Dr. Anthony Fauci<\/a> is terrorizing the public\u00a0again with endless media appearances.\u00a0 Rather than talk about medicines that can cure the coronavirus, like those given to President Trump, he is peddling fear by talking about 300,000 to 400,000 deaths.\u00a0 He pushes his favorite solutions, namely masks and lockdowns.\u00a0 Leftist media can\u2019t get enough Fauci.\u00a0 [Interestingly, he is the highest-paid federal employee with a salary of $417,608 versus $400,000 for the president.]<\/p>\n There is some mystery about why hospitalized President Trump was infused with the dubious, ultra-expensive medicine remdesivir and an experimental antibodies medicine.\u00a0 Why not use hydroxychloroquine?\u00a0 He previously took it safely and correctly promoted it.\u00a0 Mountains of evidence have vindicated him.\u00a0 HCQ has proven, better health benefits than remdesivir for treating the coronavirus.<\/p>\n Perhaps the ill disrupter president\u2019s doctors were convinced to use remdesivir by establishment interests \u2013 namely a large drug company Gilead, the Gates foundation and Fauci \u2013 rather than HCQ, used safely by millions of people worldwide.<\/p>\n Many physicians strongly believe that an HCQ cocktail makes more public health sense.\u00a0 Remdesivir can only be used for hospitalized patients.\u00a0 But millions of people could take HCQ to stay out of hospital.\u00a0 If President Trump had been given HCQ it would have promoted its wide use.\u00a0 Oops, but that would threaten the billions of dollars to be made from remdesivir.\u00a0 Such wide use of HCQ would negate the need for devastating lockdowns, a benefit not offered by remdesivir.<\/p>\n Though President Trump took HCQ as a prophylactic without any issues, he apparently did not stay on a weekly low dose together with zinc every day as many physicians believe necessary.\u00a0 Conservative pundit Dennis Prager<\/a> has been doing this for months.\u00a0 \u201cRudy Giuliani says<\/a> he is taking hydroxychloroquine despite testing negative twice for the coronavirus.\u201d \u00a0The two people sitting on either side of him at the White House Garden Amy Coney Barrett announcement event tested positive for covid. Rudy was negative.\u00a0Representative Louie Gohmert also announced<\/a> his use of HCQ.\u00a0 Brazilian President Bolsonaro proudly announced<\/a> his successful use of HCQ.<\/p>\n Call it speculation, but perhaps one reason HCQ was not given to the president is a mostly unknown lawsuit<\/a> in federal court against the federal government (FDA) by the Association of American Physicians & Surgeons.\u00a0 The goal is to protect medical freedom and unblock physician access to HCQ by releasing the government stockpile that could save thousands of lives weekly.\u00a0 It invokes \u201crelease of the HCQ Stockpile could save 50,000-100,000 American lives.\u201d\u00a0 This is forward-looking, but the same numbers apply to past death numbers: As much as half or more of the over 200,000 deaths were preventable! Maybe some senior advisors warned the president that using HCQ might lose the case.\u00a0 Just maybe.<\/p>\n For months articles appeared highlighting the competition between HCQ and remdesivir to fight the pandemic.\u00a0 But the competition was lopsided, like a kite competing against a jet plane.\u00a0 Why?\u00a0 So much money and powerful people pushing remdesivir.\u00a0 So little money to be made from using HCQ.<\/p>\n What about the medical and scientific proof?\u00a0 It is like night and day.\u00a0 Remdesivir has only been shown to modestly reduce hospital time by a few days.\u00a0 In contrast, HCQ in countless studies has been shown<\/a> to cut hospitalizations and deaths.\u00a0 When remdesivir was in clinical studies the government (Fauci) and Gilead cleverly changed what measured outcome effectiveness.\u00a0 The protocol was changed<\/a> after the trial started.\u00a0 Rather than measure death, length of hospital stay, a far less rigorous measure, was deemed to determine success against COVID-19.\u00a0 Why?\u00a0 Because remdesivir did not reduce the death rate.\u00a0 With billions of dollars at stake, they needed a way to make the drug a market success, despite a cost of thousands of dollars per patient.<\/p>\n Also, the government approved the drug even though phase three of the randomized clinical study had not been completed.\u00a0 Note that Fauci blocked HCQ because of a lack of an acceptable randomized study.<\/p>\n Data on remdesvir just published<\/a> shows it \u201chad little effect in patients with moderate COVID-19 in 105 hospitals in the United States, Europe, and Asia in a randomized, controlled trial\u2026 adding to a mixed picture of the drug in randomized clinical trials (RCTs), which are considered the gold standard for gauging interventions.\u201d\u00a0 Similarly, a physician on an emergency medicine blog<\/a> presented a detailed analysis and concluded \u201cCombining all the evidence we have thus far, remdesivir is far from a savior in COVID-19.\u201d<\/p>\n In a strange timing coincidence, the same day that news hit about Trump catching the virus The Washington Post had a major story<\/a> with the headline \u201cRemdesivir may not cure coronavirus, but it\u2019s on track to make billions for Gilead.\u201d\u00a0 What first appears as a puff piece promoting remdesivir reveals on close reading a number of points that should shake up people.<\/p>\n Here are some examples:<\/p>\n As to granting standard of care recognition for remdesivir, it has been noted<\/a> that the National Institutes of Health (NIH) panel had members with financial ties to the manufacturer, Gilead, and that the same panel ruled against HCQ as a standard of care.<\/p>\n Back in May, it was noted<\/a> correctly that \u201cthere is no fair test of the two top contending treatments being conducted.\u201d\u00a0 Fauci was clearly seen as a promoter of remdesivir.\u00a0 And, just as more work would show, this article correctly noted the serious side-effect, namely \u201cabnormal liver function.\u201d<\/p>\n Indeed, the European drugs regulator said<\/a> recently that its safety committee was reviewing reports of acute kidney injury in some COVID-19 patients who had been given remdesivir.\u00a0 A noted researcher concluded<\/a>: \u201cRemdesivir can cause severe kidney failure (requiring dialysis, kidney transplant), liver failure, genetic mutation, heart problems up to cardiac arrest, among others. This is the truth.\u201d<\/p>\n Another source said<\/a> we \u201cstrongly believe that Veklury (remdesivir) is a harmful drug and that this evidence has been concealed by Gilead.\u00a0 We believe that the lobbying operation conducted in the media and certain public health authorities in order to discredit hydroxychloroquine, specifically in hospitals, was intended to make Velkury (remdesivir) the only solution in this situation.\u201d<\/p>\n Trump will have to be checked for some time for side effects from remdesivir.<\/p>\n In contrast, Dr. Scott Atlas who is on the White House pandemic task force has said:<\/a> \u201cWhat\u2019s happened with hydroxychloroquine is that the system has gone mad.\u00a0 \u2026 Hydroxychloroquine is super safe.\u201d<\/p>\n Also, there are no health concerns yet about the still experimental antibodies medicine from Regeneron also given to President Trump.<\/p>\n Recently, a noted physician said<\/a>, \u201cRemdesivir\u2019s fight against Hydroxychloroquine (HCQ) is somewhat symbolic of the fight of medical journals, of corrupt institutions against field medicine, of the many general practitioners who are at the bedside.\u201d<\/p>\n Letting physicians use HCQ use would greatly reduce dependence on a vaccine.\u00a0 It is perfectly consistent with the Great Barrington Declaration<\/a>, a highly praised strategy to curb lockdowns and open up society and the economy.<\/p>\n Important new positive results on HCQ merit attention.\u00a0 Recently a California doctor received attention when he went public<\/a> that he had successfully used an HCQ cocktail to cure over 1,700 people of the virus without any deaths.\u00a0 That could be done safely for millions of Americans.\u00a0 Doctor Tyson said that between 75 and 80 percent of the over 200,000 deaths thus far could have been prevented by using HCQ.\u00a0 If the leftist media was not biased, that would be national news. That some doctors are using HCQ despite the hazards they face helps explain the lower death rate despite rising cases of the coronavirus.<\/p>\n A new report looked at five randomized controlled clinical trials enrolling 5,577 outpatients in the US, Canada and Spain; it found HCQ used for prophylaxis or early treatment was associated with a 24 percent reduction in COVID-19 infection, hospitalization or death without serious adverse events.\u00a0 If zinc had also been used, more success would have been\u00a0likely.\u00a0 This is the latest of 133 studies<\/a> of early treatment with HCQ, all positive with a median improvement of 64 percent.\u00a0 Follow the science, not Fauci!\u00a0 Give our doctors medical freedom to prescribe their patients what they believe most effective.<\/p>\n In sum, the president has been given three prescription medicines, including a new antibodies cocktail (from Regeneron) that the president has spoken about very positively [and which Fauci immediately downplayed], a traditional steroid as well as remdesivir that the president has not talked about.\u00a0 But no HCQ.\u00a0 One can only imagine the demand from ordinary Americans for such a powerful VIP treatment regime.\u00a0 The president deserved a powerful approach, and it seems totally effective.\u00a0 But the nonuse of HCQ merits discussion.<\/p>\n Dr. Hirschhorn has a Ph.D. in Materials Engineering. He has\u00a0a long history of working on health issues, including being a full professor at the University of Wisconsin, Madison, a senior official at the Congressional Office of Technology Assessment and the National Governors Association.\u00a0 He has authored a number of books and hundreds of articles and has served as an executive volunteer at a major hospital for over ten years.\u00a0<\/em><\/p>\n\n